Suppr超能文献

Caco-2细胞基底外侧肽转运体对非肽类化合物的识别及转运特性

Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.

作者信息

Irie M, Terada T, Sawada K, Saito H, Inui K

机构信息

Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto, Japan.

出版信息

J Pharmacol Exp Ther. 2001 Aug;298(2):711-7.

Abstract

Recent studies have revealed that diverse compounds lacking peptide bonds, such as valacyclovir and delta-aminolevulinic acid (delta-ALA), can be recognized by H+-coupled peptide transporters (PEPT1 and PEPT2). In the present study, recognition and transport characteristics of nonpeptidic compounds by the basolateral peptide transporter, which is distinct from PEPTs, were compared with those by PEPT1 using the human intestinal Caco-2 cells. [14C]Glycylsarcosine uptake via PEPT1 was inhibited by all nonpeptidic compounds tested. Similarly, most nonpeptidic compounds showed an inhibitory effect on [14C]glycylsarcosine uptake by the basolateral peptide transporter, although some kinds of nonpeptidic compounds, such as valine methyl ester, did not. Direct measurements of valacyclovir and delta-ALA transport revealed that both compounds were able to be transported by the basolateral peptide transporter. Because delta-ALA has been used recently in vitro and in clinical studies as an endogenous photosensitizer for photodynamic therapy, the intestinal transport characteristics of delta-ALA were further examined. Inhibition studies and Eadie-Hofstee plot analysis suggested that delta-ALA transport across the brush-border and basolateral membranes of the intestine was mainly mediated by peptide transporters. In addition, the apical-to-basolateral transport of delta-ALA was greater than that of the opposite direction. These findings provide the first evidence that the intestinal basolateral peptide transporter can recognize and transport nonpeptidic compounds, and play a definitive role in the absorption of delta-ALA.

摘要

最近的研究表明,多种缺乏肽键的化合物,如伐昔洛韦和δ-氨基乙酰丙酸(δ-ALA),可被H⁺偶联肽转运体(PEPT1和PEPT2)识别。在本研究中,使用人肠道Caco-2细胞,将与PEPTs不同的基底侧肽转运体对非肽类化合物的识别和转运特性与PEPT1的进行了比较。通过PEPT1摄取[¹⁴C]甘氨酰肌氨酸受到所有测试的非肽类化合物的抑制。同样,大多数非肽类化合物对基底侧肽转运体摄取[¹⁴C]甘氨酰肌氨酸也有抑制作用,尽管某些非肽类化合物,如缬氨酸甲酯,没有这种作用。对伐昔洛韦和δ-ALA转运的直接测量表明,这两种化合物都能够被基底侧肽转运体转运。由于δ-ALA最近已在体外和临床研究中用作光动力疗法的内源性光敏剂,因此对δ-ALA的肠道转运特性进行了进一步研究。抑制研究和伊迪-霍夫斯泰分析表明,δ-ALA跨肠刷状缘膜和基底侧膜的转运主要由肽转运体介导。此外,δ-ALA从顶端到基底侧的转运大于相反方向的转运。这些发现首次证明肠道基底侧肽转运体能够识别和转运非肽类化合物,并在δ-ALA的吸收中起决定性作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验